08/01/2025
7:52 PM | Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
| Form SCHEDULE 13D/A | |
07/25/2025
7:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
6:15 PM | Alzamend Neuro (Subject)
Hyperscale Data, Inc. (Reporting)
Hyperscale Data, Inc. (Reporting)
| Form 144/A | |
07/09/2025
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
6:49 PM | Alzamend Neuro (Subject)
Hyperscale Data, Inc. (Reporting)
Hyperscale Data, Inc. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2025
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
11:15 PM | Alzamend Neuro (Filer)
| Form EFFECT | |
04/09/2025
5:06 AM | Alzamend Neuro (Filer)
| Form 424B3 | |
03/27/2025
3:30 PM | Alzamend Neuro (Filer)
| Form S-1/A | |
03/27/2025
6:30 AM | Alzamend Neuro (Issuer)
Horne William B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. |
03/25/2025
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
6:30 AM | Alzamend Neuro (Issuer)
Katzoff David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:30 PM | Alzamend Neuro (Issuer)
Horne William B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:00 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
03/19/2025
3:30 PM | Alzamend Neuro (Issuer)
Horne William B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:12 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:30 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
03/14/2025
4:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/03/2025
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
3:45 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
12/12/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
MarketBeat All Access